Home About Us Writing a Scientific Article Author's Instruction Contact us
 

MERIT RESEARCH JOURNAL OF MEDICINE AND MEDICAL SCIENCES (MRJMMS) (ISSN: 2354-323X)

 
 

/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /

 
 


July 2020 Vol. 8 No.7

Other viewing option


Abstract
Full text
Reprint (PDF) (168 KB)

Search Pubmed for articles by:
 

Hasan HA
Jawad MA

Other links:
PubMed Citation
Related articles in PubMed

















































































































































































































 

Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 8(7) pp. 327-332, July, 2020 

Copyright 2020 Author(s) retain the copyright of this article
DOI: 10.5281/zenodo.3961735


Original Research Article

Polycystic Ovary Syndrome: does it Increase the Level of Cancer Antigen125?

 
 
 

Hanan Abdulmaged Hasan1, Mohammad Oda Selman2*, Mufeeda Ali Jawad3**

 

1M.B.ch.B., High Institute of Infertility, Diagnosis and Treatment/AL-Nahrain University, IRAQ / BAGHDAD
2Professor Dr. High Institute of Infertility, Diagnosis and Treatment/AL-Nahrain University, IRAQ/BAGHDAD
3M.B.ch. B/DOG/F.I.B.O.G. Assistant Professor Dr. High Institute of Infertility, Diagnosis and Treatment/AL-Nahrain University, IRAQ / BAGHDAD

*Corresponding Author's E-mail: mohammadoda@yahoo.com

Received: 12 July 2020  I  Accepted: 22 July 2020  I  Published: 28 July 2020
Copyright 2020 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.

 

Abstract

 

PolyCystic Ovary Syndrome(PCOS) is an important cause of androgen excess, menstrual irregularity, and cardiometabolic dysfunction in women. Long term manifestations such as gynaecological malignancies, like endometrial carcinoma increased to more than three folds due to endometrial hyperplasia resulting from chronic anovulation and obesity. Cancer antigen 125(CA125) glycoprotein mucin in nature tumour marker is valuable in screening for ovarian and endometrial malignancies, monitoring therapy, early detection of recurrence and, prognosis of these cancers. This study is arranged as PCOS women are considered risky group and CA125 early screening may make a change in the type of treatment. This study was done in Iraq in 2019 between July and October Forty women aged 18-42 year were included they were distributed into two groups, PCOS group, and non PCOS group. BMI was within normal for both groups. Blood samples were taken in early follicular phase for assessing luteinizing hormone (LH), follicular stimulating hormone (FSH) and free testosterone (FT) hormone. Other blood samples were taken at late follicular phase to calculate CA125levels using enzyme linked immunosorbent assay (ELISA). This study revealed no significant difference in CA125 between normal group and PCOS group .In spite of the hormonal disturbance in PCOS and increasing risk of malignancy, CA 125 was not increased in non-cancerous patients

Keywords: Body Mass Index (BMI), Cancer antigen CA125, Polycystic ovarian Syndrome (PCOS)




























 







 








 





















 









































































 










 







































 










 

 
 
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
                         

Merit Research Journals 2020 || Advertisement | Privacy policy.